Bacterial Meningitis in Burkina Faso: Surveillance Using Field-Based Polymerase Chain Reaction Testing
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
BACKGROUND: In addition to frequent epidemics of group A meningococcal disease, endemic bacterial meningitis due mostly to Neisseria meningitidis, pneumococcus, and Haemophilus influenzae type b is a serious problem in sub-Saharan Africa. The improved ability to identify the etiologic agent in cases of bacterial meningitis will facilitate more rapid administration of precise therapy. METHODS: To describe the epidemiology of bacterial meningitis and evaluate the usefulness of field-based polymerase chain reaction (PCR) testing, we implemented population-based meningitis surveillance in Burkina Faso during 2002-2003 by use of PCR, culture, and antigen detection tests. RESULTS: Among persons aged 1 month to 67 years, the incidences of meningococcal meningitis, pneumococcal meningitis, and Haemophilus influenzae type b meningitis were 19 cases (n=179), 17 cases (n=162), and 7.1 cases (n=68) per 100,000 persons per year, respectively. Of the cases of meningococcal meningitis, 72% were due to N. meningitidis serogroup W135. Pneumococcal meningitis caused 61% of deaths and occurred in a seasonal pattern that was similar to that of meningococcal meningitis. Of cases of pneumococcal meningitis and N. meningitidis serogroup W135 meningitis, 71% occurred among persons >2 years of age. Most patients, regardless of the etiology of their illness and the existence of an epidemic, received short-course therapy with oily chloramphenicol. Compared with culture as the gold standard, the sensitivity and specificity of PCR in the field were high; this result was confirmed in Burkina Faso and Paris. CONCLUSIONS: Precise and rapid identification of etiologic agents is critical for improvement in the treatment and prevention of meningitis, and, thus, PCR should be considered for wider use in Africa. Vaccines against Streptococcus pneumoniae, N. meningitidis (including serogroup W135), and H. influenzae type b all will have a major impact on the bacterial meningitis burden. Antibiotic recommendations need to consider the importance of S. pneumoniae, even during the epidemic season.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The reported sensitivity of PCR for pneumococcal meningitis is high and reached 100% in the majority of conducted studies (median of 100%, range 79%–100%) (Table 1; see also Table S1 in the supplemental material) (49–58).”
From Molecular diagnostics in cerebrospinal fluid for the diagnosis of central nervous system infections (2024) · cites this paper as [58]
In the citing paper
“The sensitivity of bexA PCR ranged from 81% to 100% with a median of 93%, with a specificity ranging from 81% to 100% (median 94%) (54, 58, 65–68).”
From Molecular diagnostics in cerebrospinal fluid for the diagnosis of central nervous system infections (2024) · cites this paper as [58]
In the citing paper
“Other studies looking at single organism-specific PCR or multiplex assays for a variety of organisms, such as H. influenzae, S. pneumoniae, and N. meningitidis, have demonstrated increased sensitivity compared to conventional methods (28–30).”
From Multicenter Evaluation of BioFire FilmArray Meningitis/Encephalitis Panel for Detection of Bacteria, Viruses, and Yeast in Cerebrospinal Fluid Specimens (2016) · cites this paper as [30]
Citations
Cites
Bulletin of the World Health Organization
C., N. H. (1955) · The British Journal of Sociology · doi:10.2307/587237 · Cited by 3,601
Bulletin of the World Health Organization
Frick, K. D., Lynch, M. C., West, S. K., Muñoz, B., & Mkocha, H. A. (2003) · Bulletin of the World Health Organization · Cited by 2,660
Corless, C. E., Guiver, M., Borrow, R., Edwards-Jones, V., Fox, A. J., & Kaczmarski, E. B. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.4.1553-1558.2001 · Cited by 607
Serotype Antigens of Neisseria meningitidis and a Proposed Scbemefor Designation of Serotypes
Frasch, C. E., Zollinger, W. D., & Poolman, J. T. (1985) · Clinical Infectious Diseases · doi:10.1093/clinids/7.4.504 · Cited by 460
Tunkel, A. R. (2001) · Cited by 308
Serogroup W135 meningococcal disease in Hajj pilgrims
Taha, M.-K., Achtman, M., Alonso, J.-M., Greenwood, B., Ramsay, M., Fox, A., Gray, S., & Kaczmarski, E. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03502-9 · Cited by 267 · cited 1×
“meningitidis serogroup W135 meningitis has been recognized since 1982 [4], but outbreaks have been documented only recently [5-8].”
BackgroundSelf-citationTaha, M.-K. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.2.855-857.2000 · Cited by 260 · cited 2×
“PCR has a high sensitivity and specificity [12, 13, 15], and the lower limit of bacterial concentrations necessary for detection are such that false-positive results caused by transient contamination (e.”
BackgroundSelf-citationFailure of chloramphenicol therapy in penicillin-resistant pneumococcal meningitis
Friedland, I. R., Klugman, K. P., & Klugman, K. P. (1992) · The Lancet · doi:10.1016/0140-6736(92)90087-j · Cited by 191 · cited 1×
“Although few data exist with regard to efficacy, the use of chloramphenicol therapy for pneumococcal meningitis may lead to treatment failure [39], a situation that likely will worsen with the spread of chloramphenicol-resistant organisms [40, 41].”
BackgroundEpidemiology of bacterial meningitis in Niamey, Niger, 1981-96.
Campagne, G., Schuchat, A., Djibo, S., Ousseini, A., Cissé, L., & Chippaux, J. (1999) · Europe PMC (PubMed Central) · Cited by 182
Rådström, P., Bäckman, A., Qian, N., Kragsbjerg, P., Påhlson, C., & Olcén, P. (1994) · Journal of Clinical Microbiology · doi:10.1128/jcm.32.11.2738-2744.1994 · Cited by 179 · cited 1×
“, nasopharyngeal carriage) are unlikely to occur [22-24].”
Background
Research works printed but not linked: 5
- Campagne, 1999, Bulletin of the World Health Organization, 77, 499
- 1982, Lancet, 11, 1335
- 2003, Emerging infectious diseases, 9, 486
- 2001, 19, 3420
- 2001, Bulletin de la Soci t de pathologie exotique (1990), 94, 300
Cited by
O'Brien, K. L., Wolfson, L. J., Watt, J. P., Henkle, E., Deloria-Knoll, M., McCall, N., Lee, E., Mulholland, K., Levine, O. S., & Cherian, T. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61204-6 · Cited by 2,398
Epidemiology, Diagnosis, and Antimicrobial Treatment of Acute Bacterial Meningitis
Brouwer, M. C., Tunkel, A. R., & van de Beek, D. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00070-09 · Cited by 930
ESCMID guideline: diagnosis and treatment of acute bacterial meningitis
van de Beek, D., Cabellos, C., Dzupova, O., Esposito, S., Klein, M., Kloek, A. T., Leib, S. L., Mourvillier, B., Ostergaard, C., Pagliano, P., et al. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.01.007 · Cited by 919
Global epidemiology of meningococcal disease
Harrison, L. H., Trotter, C. L., & Ramsay, M. E. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.04.063 · Cited by 755
Laboratory medicine in Africa: a barrier to effective health care
Petti, C. A., Polage, C. R., Quinn, T. C., Ronald, A. R., & Sande, M. A. (2006) · Clinical Infectious Diseases · doi:10.1086/499363 · Cited by 749
“Two landmark studies published recently have contributed significantly to our understanding of the etiology of febrile illness in Kenya and Burkina Faso and demonstrate the need for physicians to consider alternative diagnoses in their clinical practice [3, 7, 8].”
BackgroundLeber, A. L., Everhart, K., Balada-Llasat, J.-M., Cullison, J., Daly, J., Holt, S., Lephart, P., Salimnia, H., Schreckenberger, P. C., DesJarlais, S., et al. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.00730-16 · Cited by 609
Pathogens Associated With Sepsis in Newborns and Young Infants in Developing Countries
Zaidi, A. K. M., Thaver, D., Ali, S. A., & Khan, T. A. (2009) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3181958769 · Cited by 385
Effect of vaccines on bacterial meningitis worldwide
McIntyre, P. B., O'Brien, K. L., Greenwood, B., & van de Beek, D. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61187-8 · Cited by 326
Community-acquired bacterial meningitis
van de Beek, D., Brouwer, M., Hasbun, R., Koedel, U., Whitney, C. G., & Wijdicks, E. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.74 · Cited by 312
Dilemmas in the diagnosis of acute community-acquired bacterial meningitis
Brouwer, M. C., Thwaites, G. E., Tunkel, A. R., & van de Beek, D. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61185-4 · Cited by 302
Meningococcal Meningitis: Unprecedented Incidence of Serogroup X--Related Cases in 2006 in Niger
Boisier, P., Nicolas, P., Djibo, S., Taha, M.-K., Jeanne, I., Mainassara, H. B., Tenebray, B., Kairo, K. K., Giorgini, D., & Chanteau, S. (2007) · Clinical Infectious Diseases · doi:10.1086/511646 · Cited by 237
“In 2002, the first epidemic ever identified in Africa as being caused by Nm serogroup W135 occurred in Burkina Faso [9] [10], and the risk of a rapid spread of the epidemic within the meningitis belt was considered to be high.”
BackgroundInfluentialSelf-citationLeimkugel, J., Adams Forgor, A., Gagneux, S., Pflüger, V., Flierl, C., Awine, E., Naegeli, M., Dangy, J., Smith, T., Hodgson, A., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/431151 · Cited by 214
“Serotype 1 dominance and a broad host age range also seem to be features of the current pneumococcal meningitis situation in Burkina Faso [34, 35].”
BackgroundProspects for Vaccine Prevention of Meningococcal Infection
Harrison, L. H. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.19.1.142-164.2006 · Cited by 178
“meningitidis from a normally sterile body fluid or the detection of meningococcal DNA by PCR (36, 71, 87, 259, 321).”
BackgroundLaboratory Diagnosis of Invasive Pneumococcal Disease
Reller, L. B., Weinstein, M. P., Werno, A. M., & Murdoch, D. R. (2008) · Clinical Infectious Diseases · doi:10.1086/528798 · Cited by 160
LaForce, F. M., Ravenscroft, N., Djingarey, M. H., & Viviani, S. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.04.062 · Cited by 161
“improved laboratory diagnoses [16].”
Yaro, S., Lourd, M., Traoré, Y., Njanpop‐Lafourcade, B., Sawadogo, A., Sangaré, L., Hien, A., Ouedraogo, M. S., Sanou, O., du Châtelet, I. P., et al. (2006) · Clinical Infectious Diseases · doi:10.1086/506940 · Cited by 134
Self-citationEmergence of Epidemic Neisseria meningitidis Serogroup X Meningitis in Togo and Burkina Faso
Delrieu, I., Yaro, S., Tamekloe, T. A., Njanpop‐Lafourcade, B., Tall, H., Jaillard, P., Ouedraogo, M. S., Badziklou, K., Sanou, O., Drabo, A., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019513 · Cited by 135
“Multivariate logistic regression analyses included suspected cases identified in sentinel surveillance in Togo, the Bobo-Dioulasso surveillance study and passive surveillance in western Burkina Faso.”
MethodInfluentialSelf-citationA hypothetical explanatory model for meningococcal meningitis in the African meningitis belt
Mueller, J. E., & Gessner, B. D. (2009) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2009.08.013 · Cited by 128
Self-citationThe roles of pneumococcal serotypes 1 and 5 in paediatric invasive disease
Hausdorff, W. P. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.09.009 · Cited by 115
Emergence of serogroup X meningococcal disease in Africa: Need for a vaccine
Xie, O., Pollard, A. J., Mueller, J. E., & Norheim, G. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.04.036 · Cited by 126
Editorial: 100 years of epidemic meningitis in West Africa – has anything changed?
Greenwood, B. M. (2006) · Tropical Medicine & International Health · doi:10.1111/j.1365-3156.2006.01639.x · Cited by 106
“Multiplex PCR assays that can be done on stored samples (Parent du Châtelet et al. 2005) make identification of the cause of outbreaks much easier than was the case in the past.”
BackgroundMustapha, M. M., Marsh, J. W., & Harrison, L. H. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.02.014 · Cited by 103
Kwambana-Adams, B., Asiedu‐Bekoe, F., Sarkodie, B., Afreh, O. K., Kuma, G. K., Owusu-Okyere, G., Foster-Nyarko, E., Ohene, S.-A., Okot, C. L., Worwui, A. K., et al. (2016) · BMC Infectious Diseases · doi:10.1186/s12879-016-1914-3 · Cited by 94
Moïsi, J. C., Saha, S. K., Falade, A. G., Njanpop‐Lafourcade, B., Oundo, J., Zaidi, A. K. M., Afroj, S., Bakare, R. A., Buss, J. K., Lasi, R., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/596481 · Cited by 86
“Epidemiological studies in Africa have consistently documented high incidence rates of laboratory-confirmed bacterial meningitis [1, 6, 26-29], but most studies conducted in Asia Moïsi et al.”
Self-citationTraoré, Y., Njanpop‐Lafourcade, B., Adjogble, K., Lourd, M., Yaro, S., Nacro, B., Drabo, A., du Châtelet, I. P., Mueller, J. E., Taha, M., et al. (2006) · Clinical Infectious Diseases · doi:10.1086/507339 · Cited by 84
“as a new epidemic serogroup in 2001 [2, 3].”
BackgroundSelf-citationAgier, L., Martiny, N., Thiongane, O., Mueller, J. E., Paireau, J., Watkins, E., Irving, T., Koutangni, T., & Broutin, H. (2016) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2016.10.032 · Cited by 83
Daza, P., Banda, R., Misoya, K., Katsulukuta, A., Gessner, B. D., Katsande, R., Mhlanga, B. R., Mueller, J. E., Nelson, C. B., Phiri, A., et al. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.05.076 · Cited by 71
Self-citationLaboratory-based surveillance of patients with bacterial meningitis in Egypt (1998–2004)
Afifi, S., Wasfy, M. O., Azab, M. A., Youssef, F. G., Pimentel, G., Graham, T. W., Mansour, H., El-Sayed, N., Earhart, K. C., Hajjeh, R. A., et al. (2007) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-007-0280-x · Cited by 71
“influenzae serotype b [34, 35].”
KENNEDY, W. A., CHANG, S.-J., PURDY, K., LE, T., KILGORE, P. E., KIM, J. S., ANH, D. D., HUONG, P. L. T., DONG, B. Q., TAN, D. M., et al. (2007) · Epidemiology and Infection · doi:10.1017/s0950268806007734 · Cited by 66
“Unlike the study from Burkina Faso [17] where >95% of Hib and Sp culture-positive CSFs were also LA positive, our results showed that the LA testing of CSF lacked sensitivity in case detection.”
BackgroundResultMueller, J. E., Yaro, S., Ouedraogo, M. S., Levina, N., Njanpop‐Lafourcade, B., Tall, H., Idohou, R. S., Sanou, O., Kroman, S. S., Drabo, A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052464 · Cited by 65
Self-citationFindlow, H., Vogel, U. F., Mueller, J. E., Curry, A., Njanpop‐Lafourcade, B., Claus, H., Gray, S. J., Yaro, S., Traoré, Y., Sangaré, L., et al. (2007) · The Journal of Infectious Diseases · doi:10.1086/512084 · Cited by 64
Self-citationChanteau, S., Sidikou, F., Djibo, S., Moussa, A., Mindadou, H., & Boisier, P. (2006) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/j.trstmh.2005.09.006 · Cited by 61
Management of bacterial central nervous system infections
Brouwer, M. C., & van de Beek, D. (2017) · Handbook of clinical neurology · doi:10.1016/b978-0-444-63600-3.00019-2 · Cited by 61
Impact of the hajj on pneumococcal transmission
Memish, Z. A., Assiri, A. M., Almasri, M. M., Alhakeem, R. F., Turkestani, A., Rabeeah, A. A. A., Akkad, N., Yezli, S., Klugman, K. P., O’Brien, K. L., et al. (2014) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2014.07.005 · Cited by 55
“Serotypes with higher invasive indices can cause endemic disease, for example in the African meningitis belt [28–30], as well as localized outbreaks [31–33].”
BackgroundSelf-citationFalade, A. G., Lagunju, I. A., Bakare, R. A., Odekanmi, A. A., & Adegbola, R. A. (2009) · Clinical Infectious Diseases · doi:10.1086/596500 · Cited by 54
“In Africa, S. pneumoniae has been reported to be a major cause of childhood disease, with high incidence rates documented in The Gambia [16–18], Kenya at C arleton U niversity on June 26, 2015 http://cid.oxfordjournals.org/ D ow nloaded from Pneumococcal Disease Surveillance in Nigeria • CID 2009:48 (Suppl 2) • S195 […”
ResultFranco-Paredes, C., Lammoglia, L., Hernández, I., & Santos-Preciado, J. I. (2008) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2007.09.012 · Cited by 51
Evaluation and selection of tandem repeat loci for Streptococcus pneumoniae MLVA strain typing
Koeck, J., Njanpop‐Lafourcade, B., Cade, S., Varon, E., Sangaré, L., Valjevac, S., Vergnaud, G., & Pourcel, C. (2005) · BMC Microbiology · doi:10.1186/1471-2180-5-66 · Cited by 52
“RP1 to RP13 and RP46 to RP55 were isolated from cerebro-spinal fluid of patients with meningitis in Bobo-Dioulasso (Burkina Faso) by the "Association pour l'Aide à la Médecine Préventive" (AMP IPP) [2].”
InfluentialSelf-citationRaghunathan, P. L., Jones, J. D., Tiendrebeogo, S. R. M., Sanou, I., Sangaré, L., Kouanda, S., Dabal, M., Lingani, C., Elie, C. M., Johnson, S., et al. (2006) · The Journal of Infectious Diseases · doi:10.1086/499822 · Cited by 52
“Enhanced surveillance and laboratory confirmation of meningococcal disease [52, 53] are necessary for the detection of African epidemics and for response with the appropriate bivalent A/C or trivalent A/C/W-135 polysaccharide vaccines [47].”
BackgroundSelf-citationCase-fatality ratio of bacterial meningitis in the African meningitis belt: We can do better
Boisier, P., Maïnassara, H. B., Sidikou, F., Djibo, S., Kairo, K. K., & Chanteau, S. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.04.036 · Cited by 54
Broad-range real time PCR and DNA sequencing for the diagnosis of bacterial meningitis
Deutch, S., Pedersen, L. N., Pødenphant, L., Olesen, R., Schmidt, M. B., Møller, J. K., & Østergaard, L. J. (2005) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540500372861 · Cited by 48
“Accurate aetiological diagnosis is also important for epidemiological surveillance [5,6].”
BackgroundKambiré, D., Soeters, H. M., Ouedraogo-Traoré, R., Médah, I., Sangaré, L., Yaméogo, I., Sawadogo, G., Ouédraogo, A., Ouangraoua, S., McGee, L., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0166384 · Cited by 52
Neisseria meningitidisSerogroups A and W‐135: Carriage and Immunity in Burkina Faso, 2003
Mueller, J. E., Yaro, S., Traoré, Y., Sangaré, L., Tarnagda, Z., Njanpop‐Lafourcade, B., Borrow, R., & Gessner, B. D. (2006) · The Journal of Infectious Diseases · doi:10.1086/500511 · Cited by 44
Self-citationPneumococcal polysaccharide vaccines
Jackson, L. A. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-0090-5.00033-1 · Cited by 47
Tam, P. I., Thielen, B. K., Obaro, S., Brearley, A. M., Kaizer, A. M., Chu, H., & Janoff, E. N. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.02.045 · Cited by 47
“One study confirmed culture results with molecular diagnostics (PCR) [14], and four compared culture and PCR on all specimens [16,18,33,34].”
BackgroundMeningococcal serogroup W135 in the African meningitis belt: epidemiology, immunity and vaccines
Mueller, J. E., Borrow, R., & Gessner, B. D. (2006) · Expert Review of Vaccines · doi:10.1586/14760584.5.3.319 · Cited by 42
Self-citationCentre National de Référence des Pneumocoques
Varon, E., & Gutmann, L. (2004) · Cited by 40
Self-citationMolecular diagnostics in cerebrospinal fluid for the diagnosis of central nervous system infections
Olie, S. E., Andersen, C. Ø., van de Beek, D., & Brouwer, M. C. (2024) · Clinical Microbiology Reviews · doi:10.1128/cmr.00021-24 · Cited by 38
“(54, 58, 65–68).”
Molecular Characteristics and Epidemiology of Meningococcal Carriage, Burkina Faso, 2003
Mueller, J. E., Sangaré, L., Njanpop‐Lafourcade, B., Tarnagda, Z., Traoré, Y., Yaro, S., Borrow, R., Gessner, B. D., & Nicolas, P. (2007) · Emerging infectious diseases · doi:10.3201/eid1306.061395 · Cited by 38
Self-citationKambiré, D., Soeters, H. M., Ouedraogo-Traoré, R., Médah, I., Sangaré, L., Yaméogo, I., Sawadogo, G., Ouédraogo, A., Ouangraoua, S., McGee, L., et al. (2017) · Journal of Infection · doi:10.1016/j.jinf.2017.12.002 · Cited by 38
Soeters, H. M., Kambiré, D., Sawadogo, G., Ouedraogo-Traoré, R., Bicaba, B. W., Médah, I., Sangaré, L., Ouédraogo, A., Ouangraoua, S., Yaméogo, I., et al. (2019) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiz301 · Cited by 37
“In the meningitis belt of sub-Saharan Africa, pneumococcal meningitis has a distinct seasonality similar to that of meningococcal meningitis, a high case fatality ratio (CFR), and a predominance of serotype 1 disease in persons aged >5 years [4-8].”
BackgroundMueller, J. E., Yaro, S., Njanpop‐Lafourcade, B., Drabo, A., Idohou, R. S., Kroman, S. S., Sanou, O., Diagbouga, S. P., Traoré, Y., Sangaré, L., et al. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir623 · Cited by 36
“The nurses in charge were asked to send all cerebrospinal fluid (CSF) samples for culture and polymerase chain reaction (PCR) analysis to Centre Muraz, Bobo-Dioulasso, to identify meningococci (including genogroup), pneumococci, or Haemophilus influenzae [4].”
MethodSelf-citationNhantumbo, A. A., Cantarelli, V. V., Caireão, J., Munguambe, A. M., Comé, C. E., Pinto, G. D. C., Zimba, T. F., Mandomando, I., Semá, C. B., Dias, C., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0138249 · Cited by 34
Norheim, G., Rosenqvist, E., Aseffa, A., Yassin, M. A., Mengistu, G., Kassu, A., Fikremariam, D., Tamire, W., Høiby, E. A., Alebel, T., et al. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.44.3.861-871.2006 · Cited by 34
“OpcA 36 (84) 10 (48) Opa type 5a 7 (16) 4 (19) 5f 13 (30) 4 (19) 5h 3 (7) 0 5i 0 2 (10) 5af 5 (12) 6 (29) 5ah 1 (2) 0 5fh 3 (7) 0 5ai 0 2 (10) NadA 10 (23) 8 (38) LOS types L3,7,9 0 3 (14) 3/3 (100) L10 10 (23) 4 (19) 14/14 (100) L11 26 (60) 12 (57) 4/38 (11) L10, L11 6 (14) 0 6/6 (100) L8, L11 1 (2) 0 1/1 (100) L3,7,…”
BackgroundResultInfluentialEtiologies of Bacterial Meningitis in Bangladesh: Results from a Hospital-Based Study
Gurley, E. S., Hossain, M. J., Montgomery, S. P., Petersen, L. R., Sejvar, J. J., Mayer, L. W., Whitney, A. M., Dull, P. M., Nahar, N., Uddin, A. K. M. R., et al. (2009) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2009.81.475 · Cited by 40
Trotter, C. L., Yaro, S., Njanpop‐Lafourcade, B., Drabo, A., Kroman, S. S., Idohou, R. S., Sanou, O., Bowen, L., Findlow, H., Diagbouga, S. P., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055486 · Cited by 35
Self-citationKhumalo, J., Nicol, M., Hardie, D., Muloiwa, R., Mteshana, P., & Bamford, C. (2017) · PLOS ONE · doi:10.1371/journal.pone.0173948 · Cited by 31
Emergency medicine updates: Evaluation and diagnosis of sepsis and septic shock
Long, B., & Gottlieb, M. A. (2025) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2025.01.055 · Cited by 34
Sié, A., Pflüger, V., Coulibaly, B., Dangy, J., Kapaun, A., Junghanss, T., Pluschke, G., & Leimkugel, J. (2008) · Tropical Medicine & International Health · doi:10.1111/j.1365-3156.2008.02056.x · Cited by 34
“Results were confirmed by multiplex polymerase chain reaction (PCR) later (Parent et al. 2005).”
Standardizing Surveillance of Pneumococcal Disease
Knoll, M. D., Moïsi, J. C., Muhib, F., Wonodi, C. B., Lee, E. H., Grant, L. R., Gilani, Z., Anude, C., O’Brien, K. L., Cherian, T., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/596480 · Cited by 32
Tall, H., Hugonnet, S., Donnen, P., Dramaix‐Wilmet, M., Kambou, J. L., Drabo, F., & Mueller, J. E. (2012) · BMC Infectious Diseases · doi:10.1186/1471-2334-12-2 · Cited by 31
“Despite the fact that pneumococci are responsible for almost half of bacterial meningitis cases in the meningitis belt [22,23] and cause meningitis with pronounced seasonality, no localised epidemic so far has been reported due to pneumococci, which suggests that the focal epidemic pattern is limited to meningococci.”
BackgroundResultDjibo, S., Njanpop‐Lafourcade, B., Boisier, P., Moussa, A., Kobo, G., Sidikou, F., Hien, A., Bieboure, G., Aguilera, J.-F., du Châtelet, I. P., et al. (2006) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/j.trstmh.2005.10.002 · Cited by 30
“…LAT kits are already available to identify meningococcal serogroups A and Y/W135: Wellcogen® (Abbott-Murex), Pastorex® (Bio-Rad) and Directigen® (Becton Dickinson) diff v v s S S s a M g 2 2 T a C p W B i w o l s 2 A c d 1994; Garcia et al., 1986; Parent du Chatelet et al., 2005; Taha, 2000).”
BackgroundMethodInfluentialSelf-citationCissé, M. F., Breugelmans, J. G., Bâ, M., Diop, M. B., Faye, P. C., Mhlanga, B. R., Mueller, J. E., Koffi, D., & Gessner, B. D. (2010) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3181ccb0a0 · Cited by 29
Self-citationDistinguishing community-acquired bacterial and viral meningitis: Microbes and biomarkers
Ivaska, L., Herberg, J., & Sadarangani, M. (2024) · Journal of Infection · doi:10.1016/j.jinf.2024.01.010 · Cited by 28
Rose, A., Mueller, J. E., Gerstl, S., Njanpop‐Lafourcade, B., Page, A., Nicolas, P., Traoré, R. O., Caugant, D. A., & Guerin, P. J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011086 · Cited by 30
“However, previous studies in sub-Saharan Africa have shown comparable sensitivity and specificity of culture and PCR if performed on fresh CSF from untreated patients [8].”
BackgroundSelf-citationNjanpop‐Lafourcade, B., du Châtelet, I. P., Sanou, O., Alonso, J., & Taha, M. (2005) · Microbes and Infection · doi:10.1016/j.micinf.2005.01.003 · Cited by 28
Self-citationOutbreak of Streptococcus pneumoniae serotype 1 pneumonia in a United Kingdom school
Gupta, A., Khaw, F. M., Stokle, E. L., George, R. C., Pebody, R. G., Stansfield, R., Sheppard, C. L., Slack, M., Gorton, R., & Spencer, D. A. (2008) · BMJ · doi:10.1136/bmj.a2964 · Cited by 28
Ibarz-Pavón, A. B., Morais, L., Sigaúque, B., Mandomando, I., Bassat, Q., Nhacolo, A., Quintó, L., Soriano‐Gabarró, M., Alonso, P. L., & Roca, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019717 · Cited by 26
Increase of meningococcal serogroup Y cases in Europe: A reason for concern?
Bröker, M., Jacobsson, S., DeTora, L. M., Pace, D., & Taha, M. (2012) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.20098 · Cited by 30
Self-citationIncrease in Neisseria meningitidis serogroup W invasive disease in Canada: 2009–2016
Tsang, R. S. W., Hoang, L., Tyrrell, G., Horsman, G. B., Caeseele, P. G. V., Jamieson, F. B., Lefebvre, B., Haldane, D. J. M., Gad, R., German, G., et al. (2017) · Canada Communicable Disease Report · doi:10.14745/ccdr.v43i78a01 · Cited by 25
“With pilgrims returning to their countries in Africa, Asia, Europe, North America and South America, this strain was disseminated globally.”
BackgroundNjanpop‐Lafourcade, B., Sanou, O., van der Linden, M., Levina, N., Karanfil, M., Yaro, S., Tamekloe, T. A., & Mueller, J. E. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.01402-09 · Cited by 24
“We used a systematic collection of 136 pneumococcal meningitis cases from surveillance carried out in Burkina Faso and Togo during 2007 and 2008 (1, 11, 16), for which either both CSF and isolates (n 52), CSF only (n 81), or isolates only (n 3) were available.”
MethodSelf-citationTsang, R. S. W., Ahmad, T., Tyler, S., Lefebvre, B., Deeks, S. L., Gilca, R., Hoang, L., Tyrrell, G. J., Caeseele, P. G. V., Domselaar, G. V., et al. (2018) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2018.01.019 · Cited by 24
Letsa, T. S., Noora, C. L., Kuma, G. K., Asiedu, E., Kye-Duodu, G., Afari, E. A., Afreh, O. K., Opare, J. K. L., Nyarko, K. M., Ameme, D. K., et al. (2018) · BMC Public Health · doi:10.1186/s12889-018-5529-z · Cited by 23
“pneumoniae with an average mortality rate of 25% despite effective antibiotic therapy and modern intensive care facilities [6].”
BackgroundChanteau, S., Rose, A., Djibo, S., Nato, F., & Boisier, P. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.04.037 · Cited by 22
Mina, Y., Schechner, V., Savion, M., Yahav, D., Bilavsky, E., Sorek, N., Ben-Zvi, H., & Adler, A. (2019) · BMC Infectious Diseases · doi:10.1186/s12879-019-4348-x · Cited by 20
Quality assessed nonculture techniques for detection and typing of meningococci
Taha, M., & Fox, A. (2006) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2006.00054.x · Cited by 20
Self-citationTsolenyanu, E., Bancroft, R. E., Sesay, A. K., Senghore, M., Fiawoo, M., Akolly, D. E., Godonou, M., Tsogbalé, N., Tigossou, S., Tientcheu, L. D., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz473 · Cited by 19
Haemophilus influenzae type b conjugate vaccine impact against purulent meningitis in Rwanda
Muganga, N., Uwimana, J., FIDELE, N., GAHIMBARE, L., Gessner, B. D., Mueller, J. E., Mhlanga, B. R., Katsande, R., Herbinger, K., & Rugambwa, C. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.06.032 · Cited by 19
Self-citationWon, H. H., Yang, S. S., Gaydos, C. A., Hardick, J. P., Ramachandran, P., Hsieh, Y., Kecojevic, A., Njanpop‐Lafourcade, B., Mueller, J. E., Tamekloe, T. A., et al. (2012) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2012.05.015 · Cited by 19
“…have recently been advanced for molecular testing (Boisier et al., 2005; Ceyhan et al., 2008; Chakrabarti et al., 2009; Chanteau et al., 2006; Chatelet et al., 2005; Chen et al., 2009; Corless et al., 2001; Duan et al., 2009; Falla et al., 1994; Lafourcade et al., 2010; Saravolatz et al.,…”
BackgroundMethodInfluentialSelf-citationDunne, E. M., Mantanitobua, S., Singh, S. P., Reyburn, R., Tuivaga, E., Rafai, E., Tikoduadua, L., Porter, B. D., Satzke, C., Strachan, J., et al. (2016) · Scientific Reports · doi:10.1038/srep39784 · Cited by 18
High risk and low prevalence diseases: Adult bacterial meningitis
Pajor, M. J., Long, B., Koyfman, A., & Liang, S. Y. (2022) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2022.12.042 · Cited by 21
Renner, L. A., Usuf, E. A., Mohammed, N. I., Ansong, D., Dankwah, T., Kusah, J. T., Owusu, S. K., Awunyo, M., Arhin, B., Addo, Y., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz464 · Cited by 19
“The CFRs for meningococcal meningitis were lower in developing countries, at about 10%–15% [9, 10].”
BackgroundTravel-relatedNeisseria meningitidisSerogroup W135 Infection, France
Taha, M., Kacou-N'douba, A., Hong, E., Deghmane, A., Giorgini, D., Okpo, S., Kangah, T., & Dosso, M. B. (2013) · Emerging infectious diseases · doi:10.3201/eid1906.120515 · Cited by 15
Self-citationPeltola, H., Roine, I., Leinonen, M., Kuisma, L., Mata, A. G., Arbo, A., Goyo, J., & Saukkoriipi, A. (2010) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3181b4f041 · Cited by 18
“The PCR technology is rather costly, but it also can be brought on site.(17) However, if transport of the specimens is needed, we see no biologic risk in the regular mail, especially if the strips are sealed in plastic bags; the relevant bacteria do not survive on filter paper.”
BackgroundTsang, R. S. W., Deeks, S. L., Wong, K., Marchand‐Austin, A., & Jamieson, F. (2016) · Canada Communicable Disease Report · doi:10.14745/ccdr.v42i12a06 · Cited by 15
“This clone has since spread to sub-Saharan Africa (16) and South America (17,18).”
BackgroundBoni-Cisse, C., Jarju, S., Bancroft, R. E., Aka, L. B. N., Koné, H., Kofi, N., Mlan, A. B., Zaba, F. S., Usuf, E. A., Ndow, P. S., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz475 · Cited by 15
Pardo, J., Klinker, K. P., Borgert, S. J., Butler, B. M., Rand, K. H., & Iovine, N. M. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.00352-14 · Cited by 15
Béresniak, A., Bertherat, E., Perea, W., Soga, G., Souley, R., Dupont, D., & Hugonnet, S. (2012) · Bulletin of the World Health Organization · doi:10.2471/blt.11.086009 · Cited by 15
Zida, S., Kolia-Diafouka, P., Kania, D., Sotto, A., Foulongne, V., Bolloré, K., Ouangraoua, S., Méda, N., Carrère‐Kremer, S., de Perre, P. V., et al. (2018) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.22719 · Cited by 16
“Mycobacterium tuberculosis 3 103 (54, 551) 26 (5-28) 3/0”
Moïsi, J. C., Makawa, M.-S., Tall, H., Agbenoko, K., Njanpop‐Lafourcade, B., Tamekloe, S., Amidou, M., Mueller, J. E., & Gessner, B. D. (2017) · PLoS ONE · doi:10.1371/journal.pone.0170412 · Cited by 13
“to algorithms published elsewhere [25,26].”
Self-citationAmidu, N., Antuamwine, B. B., Addai‐Mensah, O., Abdul-Karim, A., Azure, S., Abubakari, B. B., Abenyeri, J., Opoku, A. S., Nkukah, J. E., & Najibullah, A. S. (2019) · PLoS ONE · doi:10.1371/journal.pone.0210812 · Cited by 13
Emerging drugs for acute bacterial meningitis
Deghmane, A., Alonso, J., & Taha, M. (2009) · Expert Opinion on Emerging Drugs · doi:10.1517/14728210903120887 · Cited by 13
“In African countries, in the so-called ‘meningitis belt’, which includes all or part of several sub-Saharan countries (from Ethiopia to Senegal) up to 50% of cases of bacterial meningitis are globally due to Nm [71].”
BackgroundSelf-citationMobile Microbiological Laboratory Support for Evaluation of a Meningitis Epidemic in Northern Benin
Njanpop‐Lafourcade, B., Hugonnet, S., Djogbe, H., Kodjo, A., N’Douba, A. K., Taha, M., Stoeckel, P., & Gessner, B. D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068401 · Cited by 13
Self-citationSurveillance for Bacterial Meningitis by Means of Polymerase Chain Reaction
Robbins, J. B., Schneerson, R., & Gotschlich, E. C. (2004) · Clinical Infectious Diseases · doi:10.1086/426448 · Cited by 13
“Are we missing a causative agent that is cannot be diagnosed by our current techniques? It is likely that the contribution of Parent du Châtelet and colleagues [1] will have a positive effect on the problem of bacterial meningitis in sub-Saharan Africa, as well as in other developing countries.”
BackgroundMatos, J. D. A., Madureira, D. J., Rebelo, M. C., Hofer, C. B., & Barroso, D. E. (2006) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/s0074-02762006000500014 · Cited by 12
Sanneh, B., Okoi, C., Grey-Johnson, M., Camara, H. B., Fofana, B. K., Baldeh, I., Sey, A. P., Bah, M. L., Cham, M., Samateh, A., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz505 · Cited by 12
Thomsen, M. M., Munthe‐Fog, L., Petersen, P. T., Hillig, T., Friis-Hansen, L. J., Roed, C., Harboe, Z. B., & Brandt, C. (2023) · PLoS ONE · doi:10.1371/journal.pone.0282004 · Cited by 12
Massenet, D., Birguel, J., Azowe, F., Ebong, C., Gaké, B., Lombart, J.-P., & Boisier, P. (2013) · Pathogens and Global Health · doi:10.1179/2047773212y.0000000070 · Cited by 14
Enfermedad meningocócica invasora
Rubio, J. A. S., & Sáez, M. M. (2005) · Anales de Pediatría · doi:10.1157/13073241 · Cited by 14
Laboratory-based surveillance for patients with acute meningitis in Sudan, 2004–2005
Afifi, S., Karsany, M. S., Wasfy, M. O., Pimentel, G., Marfin, A. A., & Hajjeh, R. A. (2008) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-008-0643-y · Cited by 11
“This technique has been used successfully during outbreaks in Sudan [22] and other sub-Saharan African countries [23] and has likely had subsequent influence on determining the appropriate immunization plans and antimicrobial therapy [24].”
MethodConjugate vaccine introduction in the African meningitis belt: meeting surveillance objectives
Mueller, J. E. (2012) · Tropical Medicine & International Health · doi:10.1111/tmi.12009 · Cited by 11
“Furthermore, surveillance studies that were recently discontinued might be resumed, such as the surveillance study in western Burkina Faso (Parent du Chatelet et al. 2005; Delrieu et al. 2011)).”
Background
Metadata
- Authors
- Chatelet, I. P. D., Traore, Y., Gessner, B. D., Antignac, A., Naccro, B., Njanpop-Lafourcade, B.-M., Ouedraogo, M. S., Tiendrebeogo, S. R., Varon, E., & Taha, M. K.
- Affiliations
- Institut Pasteur (FR)
- Ministère De La Santé (BF)
- Hôpital Européen Georges-Pompidou (FR)
- Corresponding author
- Gessner, B. D.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-01-01
- Volume
- 40
- Issue
- 1
- Pages
- 17-25
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2165238552
- Cited by
- 158
- References
- 41
- Citations by year
- 2025: 1 · 2024: 2 · 2023: 3 · 2022: 3 · 2021: 2 · 2020: 2 · 2019: 7 · 2018: 6 · 2017: 11 · 2016: 11 · 2015: 5 · 2014: 9 · 2013: 10 · 2012: 12
- FWCI
- 11.69
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
- Health Sciences › Medicine › Microbiology (medical) › Bacterial Identification and Susceptibility Testing
- Health Sciences › Medicine › Epidemiology › Pneumonia and Respiratory Infections
- Keywords
- bacterial meningitis, meningitis surveillance, Neisseria meningitidis serogroup W135, pneumococcal meningitis, Haemophilus influenzae type b, Streptococcus pneumoniae, meningococcal epidemics, seasonal patterns, mortality, Burkina Faso
- MeSH terms
- Adolescent, Adult, Aged, Burkina Faso, Child, Child, Preschool, Humans, Infant, Meningitis, Haemophilus, Meningitis, Meningococcal, Meningitis, Pneumococcal, Middle Aged, Neisseria meningitidis, Population Surveillance, Quality Control, Sensitivity and Specificity, Incidence, Polymerase Chain Reaction, Meningitis, Bacterial, Haemophilus influenzae type b
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.